全球先进治疗药物市场研究报告 - 2023 年至 2030 年产业分析、规模、份额、成长、趋势与预测

全球先进治疗药物市场需求预计将从 2022 年的 285.6 亿美元达到 2030 年近 1,022.9 亿美元的市场规模，2023-2030 年研究期间CAGR为 17.29%。

先进治疗药品 (ATMP) 是一类创新疗法，涵盖一系列用于在细胞或基因层面治疗疾病和损伤的尖端医疗产品。这些疗法透过利用基因、细胞或组织来针对特定疾病或病症，提供了新的医疗方法。

市场动态

先进治疗药品 (ATMP) 市场正在几个关键因素的推动下实现成长。首先，这些疗法解决以前无法治疗或管理不善的疾病，满足癌症、遗传性疾病和退化性疾病等未满足的医疗需求。生物技术、基因编辑和组织工程的技术进步极大地促进了 ATMP 的开发和商业化。改进的技术提高了这些疗法的功效和安全性，促进了它们的采用和市场扩张。支持性监管框架和快速审批途径鼓励对 ATMP 的研究和投资。此外，研发投资的增加，加上製药公司、生技公司和学术机构之间的合作，推动了该领域的创新。全球慢性病盛行率不断上升，加上个人化医疗的转变，进一步扩大了对 ATMP 提供的标靶和个人化治疗的需求。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球先进治疗药品市场的每个细分市场进行了包容性评估。先进治疗药品产业的成长和趋势为本研究提供了整体方法。

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲先进治疗药物产品市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。先进治疗药物产品市场的主要参与者包括 Spark Therapeutics Inc.、Bluebird Bio Inc.、Novartis AG、UniQure NV、Celgene Corporation、Gilead Lifesciences Inc.、Kolon TissueGene Inc.、JCR Pharmaceuticals Co. Ltd.、Medipost、Vericel Corporation 、Pharmicell Co. Ltd、Organogenesis Inc。本部分包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布，以及其他进展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法论
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：先进治疗药品 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 按治疗类型分類的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球先进治疗药品市场分析：依治疗类型

• 按治疗类型概述
• 历史和预测数据
• 依治疗类型分析
• 细胞治疗（干细胞治疗、非干细胞治疗）
• 基因治疗
• 组织工程产品

第 6 章：全球先进治疗药品市场分析：依地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区国家/地区销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 7 章：先进治疗药品公司的竞争格局

• 先进治疗药品市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 8 章：公司简介

• 公司股份分析
• 市场集中度
• Spark Therapeutics Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Bluebird Bio Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Novartis AG
• 公司简介
• 公司收入
• 产品
• 最近的发展
• UniQure NV
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Celgene Corporation
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Gilead Lifesciences Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Kolon TissueGene Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• JCR Pharmaceuticals Co. Ltd.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Medipost
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Vericel Corporation
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Pharmicell Co. Ltd
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Organogenesis Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

The global demand for Advanced Therapy Medicinal Products Market is presumed to reach the market size of nearly USD 102.29 BN by 2030 from USD 28.56 BN in 2022 with a CAGR of 17.29% under the study period 2023 - 2030.

Advanced therapy medicinal products (ATMPs) are a category of innovative therapies that encompass a range of cutting-edge medical products used to treat diseases and injuries at the cellular or genetic level. These therapies offer novel approaches to medical treatment by utilizing genes, cells, or tissues to target specific diseases or conditions.

MARKET DYNAMICS

The Advanced therapy medicinal products (ATMPs) market is experiencing growth driven by several key factors. Firstly, these therapies address previously untreatable or inadequately managed diseases, catering to unmet medical needs in conditions like cancer, genetic disorders, and degenerative diseases. Technological advancements in biotechnology, gene editing, and tissue engineering significantly contribute to the development and commercialization of ATMPs. Improved technologies enhance the efficacy and safety of these therapies, fostering their adoption and market expansion. Supportive regulatory frameworks and expedited approval pathways encourage research and investment in ATMPs. Additionally, increased investments in research and development, coupled with collaborations between pharmaceutical companies, biotech firms, and academic institutions, drive innovation in this field. The rising prevalence of chronic diseases worldwide, coupled with the shift towards personalized medicine, further amplifies the demand for targeted and personalized therapies offered by ATMPs.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of advanced therapy medicinal products. The growth and trends of advanced therapy medicinal products industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the advanced therapy medicinal products market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Therapy Type

• Cell Therapy (Stem Cell Therapy, Non-Stem Cell Therapy)
• Gene Therapy
• Tissue Engineered Product

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Advanced Therapy Medicinal Products market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Advanced Therapy Medicinal Products market include Spark Therapeutics Inc., Bluebird Bio Inc., Novartis AG, UniQure N.V., Celgene Corporation, Gilead Lifesciences Inc., Kolon TissueGene Inc., JCR Pharmaceuticals Co. Ltd., Medipost, Vericel Corporation, Pharmicell Co. Ltd, Organogenesis Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . ADVANCED THERAPY MEDICINAL PRODUCTS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Therapy Type
  • 3.7.2 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS MARKET ANALYSIS BY THERAPY TYPE

• 5.1 Overview by Therapy Type
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Therapy Type
• 5.4 Cell Therapy (Stem Cell Therapy, Non-stem Cell Therapy) Historic and Forecast Sales by Regions
• 5.5 Gene Therapy Historic and Forecast Sales by Regions
• 5.6 Tissue Engineered Product Historic and Forecast Sales by Regions

6 . GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS MARKET ANALYSIS BY GEOGRAPHY

• 6.1. Regional Outlook
• 6.2. Introduction
• 6.3. North America Sales Analysis
  • 6.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 6.3.2. North America By Segment Sales Analysis
  • 6.3.3. North America By Country Sales Analysis
  • 6.3.4. United State Sales Analysis
  • 6.3.5. Canada Sales Analysis
  • 6.3.6. Mexico Sales Analysis
• 6.4. Europe Sales Analysis
  • 6.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 6.4.2. Europe by Segment Sales Analysis
  • 6.4.3. Europe by Country Sales Analysis
  • 6.4.4. United Kingdom Sales Analysis
  • 6.4.5. France Sales Analysis
  • 6.4.6. Germany Sales Analysis
  • 6.4.7. Italy Sales Analysis
  • 6.4.8. Russia Sales Analysis
  • 6.4.9. Rest Of Europe Sales Analysis
• 6.5. Asia Pacific Sales Analysis
  • 6.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 6.5.2. Asia Pacific by Segment Sales Analysis
  • 6.5.3. Asia Pacific by Country Sales Analysis
  • 6.5.4. China Sales Analysis
  • 6.5.5. India Sales Analysis
  • 6.5.6. Japan Sales Analysis
  • 6.5.7. South Korea Sales Analysis
  • 6.5.8. Australia Sales Analysis
  • 6.5.9. South East Asia Sales Analysis
  • 6.5.10. Rest Of Asia Pacific Sales Analysis
• 6.6. Latin America Sales Analysis
  • 6.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 6.6.2. Latin America by Segment Sales Analysis
  • 6.6.3. Latin America by Country Sales Analysis
  • 6.6.4. Brazil Sales Analysis
  • 6.6.5. Argentina Sales Analysis
  • 6.6.6. Peru Sales Analysis
  • 6.6.7. Chile Sales Analysis
  • 6.6.8. Rest of Latin America Sales Analysis
• 6.7. Middle East & Africa Sales Analysis
  • 6.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 6.7.2. Middle East & Africa by Segment Sales Analysis
  • 6.7.3. Middle East & Africa by Country Sales Analysis
  • 6.7.4. Saudi Arabia Sales Analysis
  • 6.7.5. UAE Sales Analysis
  • 6.7.6. Israel Sales Analysis
  • 6.7.7. South Africa Sales Analysis
  • 6.7.8. Rest Of Middle East And Africa Sales Analysis

7 . COMPETITIVE LANDSCAPE OF THE ADVANCED THERAPY MEDICINAL PRODUCTS COMPANIES

• 7.1. Advanced Therapy Medicinal Products Market Competition
• 7.2. Partnership/Collaboration/Agreement
• 7.3. Merger And Acquisitions
• 7.4. New Product Launch
• 7.5. Other Developments

8 . COMPANY PROFILES OF ADVANCED THERAPY MEDICINAL PRODUCTS INDUSTRY

• 8.1. Company Share Analysis
• 8.2. Market Concentration Rate
• 8.3. Spark Therapeutics Inc.
  • 8.3.1. Company Overview
  • 8.3.2. Company Revenue
  • 8.3.3. Products
  • 8.3.4. Recent Developments
• 8.4. Bluebird Bio Inc.
  • 8.4.1. Company Overview
  • 8.4.2. Company Revenue
  • 8.4.3. Products
  • 8.4.4. Recent Developments
• 8.5. Novartis AG
  • 8.5.1. Company Overview
  • 8.5.2. Company Revenue
  • 8.5.3. Products
  • 8.5.4. Recent Developments
• 8.6. UniQure N.V.
  • 8.6.1. Company Overview
  • 8.6.2. Company Revenue
  • 8.6.3. Products
  • 8.6.4. Recent Developments
• 8.7. Celgene Corporation
  • 8.7.1. Company Overview
  • 8.7.2. Company Revenue
  • 8.7.3. Products
  • 8.7.4. Recent Developments
• 8.8. Gilead Lifesciences Inc.
  • 8.8.1. Company Overview
  • 8.8.2. Company Revenue
  • 8.8.3. Products
  • 8.8.4. Recent Developments
• 8.9. Kolon TissueGene Inc.
  • 8.9.1. Company Overview
  • 8.9.2. Company Revenue
  • 8.9.3. Products
  • 8.9.4. Recent Developments
• 8.10. JCR Pharmaceuticals Co. Ltd.
  • 8.10.1. Company Overview
  • 8.10.2. Company Revenue
  • 8.10.3. Products
  • 8.10.4. Recent Developments
• 8.11. Medipost
  • 8.11.1. Company Overview
  • 8.11.2. Company Revenue
  • 8.11.3. Products
  • 8.11.4. Recent Developments
• 8.12. Vericel Corporation
  • 8.12.1. Company Overview
  • 8.12.2. Company Revenue
  • 8.12.3. Products
  • 8.12.4. Recent Developments
• 8.13. Pharmicell Co. Ltd
  • 8.13.1. Company Overview
  • 8.13.2. Company Revenue
  • 8.13.3. Products
  • 8.13.4. Recent Developments
• 8.14. Organogenesis Inc.
  • 8.14.1. Company Overview
  • 8.14.2. Company Revenue
  • 8.14.3. Products
  • 8.14.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Therapy Type (USD MN)
• Cell Therapy (Stem Cell Therapy, Non-stem Cell Therapy) Market Sales by Geography (USD MN)
• Gene Therapy Market Sales by Geography (USD MN)
• Tissue Engineered Product Market Sales by Geography (USD MN)
• Global Advanced Therapy Medicinal Products Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Advanced Therapy Medicinal Products Report
• Market Research Process
• Market Research Methodology
• Global Advanced Therapy Medicinal Products Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Therapy Type
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Therapy Type (USD MN)
• Cell Therapy (Stem Cell Therapy, Non-stem Cell Therapy) Market Sales by Geography (USD MN)
• Gene Therapy Market Sales by Geography (USD MN)
• Tissue Engineered Product Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.